Redmile Group, LLC, Director, 10% Owner at FATE THERAPEUTICS INC (FATE), bought 2,825,856 shares at $28.31 ($80.0M) on 2020-06-11, disclosed to the SEC on 2020-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.31 | 1,412,928 | $40.0M | 50.0% |
| 2 | $28.31 | 1,412,928 | $40.0M | 50.0% |
| Total | $28.31 avg | 2,825,856 | $80.0M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |